Drugs / Medical Marijuana
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03233633 | May 2017 → Aug 2022 | — | The Connecticut Hospice Inc. | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03172741 | Jan 2017 → Jan 2018 | multiple sclerosis | Colorado State University | Withdrawn | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT03224468 Comparator | Jul 2017 → Feb 2021 | anxiety, depressive disorder, insomnia | Massachusetts General Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Medical Marijuana | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03224468 ↗ |
| Route | Other | “smoked once per day” NCT03172741 ↗ |